U.S. flag

An official website of the United States government

NM_000458.4(HNF1B):c.140C>T (p.Pro47Leu) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002490424.3

Allele description [Variation Report for NM_000458.4(HNF1B):c.140C>T (p.Pro47Leu)]

NM_000458.4(HNF1B):c.140C>T (p.Pro47Leu)

Gene:
HNF1B:HNF1 homeobox B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q12
Genomic location:
Preferred name:
NM_000458.4(HNF1B):c.140C>T (p.Pro47Leu)
HGVS:
  • NC_000017.11:g.37744745G>A
  • NG_013019.2:g.5362C>T
  • NM_000458.3(HNF1B):c.140C>T
  • NM_000458.4:c.140C>TMANE SELECT
  • NM_001165923.4:c.140C>T
  • NM_001304286.2:c.140C>T
  • NP_000449.1:p.Pro47Leu
  • NP_001159395.1:p.Pro47Leu
  • NP_001291215.1:p.Pro47Leu
  • NC_000017.10:g.36104736G>A
  • NC_000017.10:g.36104736G>A
  • NM_000458.2:c.140C>T
  • NM_000458.3(HNF1B):c.140C>T
  • NM_000458.3:c.140C>T
  • NM_000458.4:c.140C>T
Protein change:
P47L
Links:
Molecular consequence:
  • NM_000458.4:c.140C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165923.4:c.140C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001304286.2:c.140C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Renal cysts and diabetes syndrome (RCAD)
Synonyms:
Maturity-onset diabetes of the young, type 5; MODY type 5; Hyperuricemic nephropathy, familial juvenile, atypical; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007669; MedGen: C0431693; Orphanet: 93111; OMIM: 137920
Name:
Type 2 diabetes mellitus
Synonyms:
DIABETES MELLITUS, TYPE 2, PROTECTION AGAINST; Type II diabetes mellitus; Diabetes mellitus, noninsulin-dependent, late onset
Identifiers:
MONDO: MONDO:0005148; MeSH: D003924; MedGen: C0011860; OMIM: 125853; Human Phenotype Ontology: HP:0005978
Name:
Nonpapillary renal cell carcinoma
Identifiers:
MONDO: MONDO:0007763; MedGen: CN074294; Orphanet: 422526; OMIM: 144700

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002787992Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 5, 2022)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002787992.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024